These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1105231)

  • 21. The benzodiazepine antagonist, Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats.
    Little HJ; Taylor SC; Nutt DJ; Cowen PJ
    Eur J Pharmacol; 1985 Jan; 107(3):375-7. PubMed ID: 3920059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy testing of valproic acid compared to ethosuximide in monkey model: II. Seizure, EEG, and diurnal variations.
    Lockard JS; Levy RH; Congdon WC; DuCharme LL; Patel IH
    Epilepsia; 1977 Jun; 18(2):205-24. PubMed ID: 406139
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of sodium dipropylacetate on experimental spike foci.
    Goldensohn ES; Bustamante LA; Lueders H; Pippenger C
    Trans Am Neurol Assoc; 1977; 102():167-9. PubMed ID: 356395
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of alcohol withdrawal seizures: the roles of diphenylhydantoin and chlordiazepoxide.
    Rothstein E
    Am J Psychiatry; 1973 Dec; 130(12):1381-2. PubMed ID: 4796341
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures.
    Kotlinska J; Liljequist S
    Psychopharmacology (Berl); 1996 Oct; 127(3):238-44. PubMed ID: 8912402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of alcohol withdrawal seizures with oral diazepam loading.
    Devenyi P; Harrison ML
    Can Med Assoc J; 1985 Apr; 132(7):798-800. PubMed ID: 3978501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concepts in drug therapy.
    Ceylon Med J; 1976 Sep; 21(3):208-9. PubMed ID: 800352
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice.
    Naassila M; Legrand E; d'Alche-Birée F; Daoust M
    Psychopharmacology (Berl); 1998 Dec; 140(4):421-8. PubMed ID: 9888617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study.
    Eyer F; Schreckenberg M; Hecht D; Adorjan K; Schuster T; Felgenhauer N; Pfab R; Strubel T; Zilker T
    Alcohol Alcohol; 2011; 46(2):177-84. PubMed ID: 21339186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of diphenylhydantoin to prevent alcohol withdrawal convulsions in mice.
    Gessner PK
    Eur J Pharmacol; 1974 Jun; 27(1):120-9. PubMed ID: 4859332
    [No Abstract]   [Full Text] [Related]  

  • 31. [Austrian complex-study on dipropylacetate. Pediatric experiences].
    Groh Ch; Rosenmayr FW
    Padiatr Padol; 1976; 11(1):178-85. PubMed ID: 814526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium valproate in benzodiazepine withdrawal.
    Apelt S; Emrich HM
    Am J Psychiatry; 1990 Jul; 147(7):950-1. PubMed ID: 2113360
    [No Abstract]   [Full Text] [Related]  

  • 33. Valproic acid and sodium valproate approved for use in epilepsy.
    FDA Drug Bull; 1978; 8(2):14-5. PubMed ID: 344120
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of a GABA transaminase inhibitor on central nervous system oxygen toxicity.
    Harel D; Raday-Bitterman N; Kerem D
    Aviat Space Environ Med; 1978 Jul; 49(7):877-9. PubMed ID: 352331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.
    Emson PC
    J Neurochem; 1976 Dec; 27(6):1489-94. PubMed ID: 794443
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of escitalopram on ethanol withdrawal syndrome in rats.
    Sağlam E; Kayir H; Celik T; Uzbay T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1027-32. PubMed ID: 16650516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence.
    Colombo G; Agabio R; Carai MA; Lobina C; Pani M; Reali R; Addolorato G; Gessa GL
    Alcohol Clin Exp Res; 2000 Jan; 24(1):58-66. PubMed ID: 10656194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats.
    Uzbay IT; Akarsu ES; Kayaalp SO
    Pharmacol Biochem Behav; 1994 Dec; 49(4):969-74. PubMed ID: 7886115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate.
    Tomlinson EB
    Proc Aust Assoc Neurol; 1974; 11():203-8. PubMed ID: 4620029
    [No Abstract]   [Full Text] [Related]  

  • 40. Early experience with sodium valproate.
    Ancamp AK; Joubert PH
    S Afr Med J; 1977 Feb; 51(9):260. PubMed ID: 322329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.